ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Gastrointestinal Drugs Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-5H11525
Home | Market Reports | Health| Pharmacy
Global Pediatric Gastrointestinal Drugs Market Research Report 2022
BUY CHAPTERS

Global Pediatric Gastrointestinal Drugs Market Research Report 2025

Code: QYRE-Auto-5H11525
Report
January 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Sanofi
Aptalis
Eisai Co Ltd
Pfizer Inc
Zeria（Tillotts）
GlaxoSmithKline PLC
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Hansen Pharmaceutical

Pediatric Gastrointestinal Drugs Market

The global market for Pediatric Gastrointestinal Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pediatric Gastrointestinal Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pediatric Gastrointestinal Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pediatric Gastrointestinal Drugs in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pediatric Gastrointestinal Drugs include AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals, Perrigo, Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Gastrointestinal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Gastrointestinal Drugs.
The Pediatric Gastrointestinal Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Gastrointestinal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Gastrointestinal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pediatric Gastrointestinal Drugs Market Report

Report Metric Details
Report Name Pediatric Gastrointestinal Drugs Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals, Perrigo, Abbott, Honz Pharmaceutical, Shandong DYNE Marine Biopharmaceutical, Sunflower Pharmaceutical, Jiangzhong Pharmaceutical, Yabao Pharmaceutical, Jumpcan Pharmaceutical, Hansen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pediatric Gastrointestinal Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pediatric Gastrointestinal Drugs Market report?

Ans: The main players in the Pediatric Gastrointestinal Drugs Market are AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals, Perrigo, Abbott, Honz Pharmaceutical, Shandong DYNE Marine Biopharmaceutical, Sunflower Pharmaceutical, Jiangzhong Pharmaceutical, Yabao Pharmaceutical, Jumpcan Pharmaceutical, Hansen Pharmaceutical

What are the Application segmentation covered in the Pediatric Gastrointestinal Drugs Market report?

Ans: The Applications covered in the Pediatric Gastrointestinal Drugs Market report are Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Pediatric Gastrointestinal Drugs Market report?

Ans: The Types covered in the Pediatric Gastrointestinal Drugs Market report are Tablets, Pills, Oral Liquid

Recommended Reports

Pediatric GI Treatments

Gastrointestinal Drugs

Digestive Disease Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Pills
1.2.4 Oral Liquid
1.3 Market by Application
1.3.1 Global Pediatric Gastrointestinal Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Gastrointestinal Drugs Market Perspective (2020-2031)
2.2 Global Pediatric Gastrointestinal Drugs Growth Trends by Region
2.2.1 Global Pediatric Gastrointestinal Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Gastrointestinal Drugs Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Gastrointestinal Drugs Market Dynamics
2.3.1 Pediatric Gastrointestinal Drugs Industry Trends
2.3.2 Pediatric Gastrointestinal Drugs Market Drivers
2.3.3 Pediatric Gastrointestinal Drugs Market Challenges
2.3.4 Pediatric Gastrointestinal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue
3.1.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue (2020-2025)
3.1.2 Global Pediatric Gastrointestinal Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Gastrointestinal Drugs Revenue
3.4 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio
3.4.1 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Gastrointestinal Drugs Revenue in 2024
3.5 Global Key Players of Pediatric Gastrointestinal Drugs Head office and Area Served
3.6 Global Key Players of Pediatric Gastrointestinal Drugs, Product and Application
3.7 Global Key Players of Pediatric Gastrointestinal Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Gastrointestinal Drugs Breakdown Data by Type
4.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2026-2031)
5 Pediatric Gastrointestinal Drugs Breakdown Data by Application
5.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Gastrointestinal Drugs Market Size (2020-2031)
6.2 North America Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025)
6.4 North America Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Gastrointestinal Drugs Market Size (2020-2031)
7.2 Europe Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025)
7.4 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Gastrointestinal Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Gastrointestinal Drugs Market Size (2020-2031)
9.2 Latin America Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025)
9.4 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Introduction
11.1.4 AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pediatric Gastrointestinal Drugs Introduction
11.2.4 Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Aptalis
11.3.1 Aptalis Company Details
11.3.2 Aptalis Business Overview
11.3.3 Aptalis Pediatric Gastrointestinal Drugs Introduction
11.3.4 Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.3.5 Aptalis Recent Development
11.4 Eisai
11.4.1 Eisai Company Details
11.4.2 Eisai Business Overview
11.4.3 Eisai Pediatric Gastrointestinal Drugs Introduction
11.4.4 Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.4.5 Eisai Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Pediatric Gastrointestinal Drugs Introduction
11.5.4 Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Zeria (Tillotts)
11.6.1 Zeria (Tillotts) Company Details
11.6.2 Zeria (Tillotts) Business Overview
11.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Introduction
11.6.4 Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.6.5 Zeria (Tillotts) Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Introduction
11.7.4 GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 Salix Pharmaceuticals
11.8.1 Salix Pharmaceuticals Company Details
11.8.2 Salix Pharmaceuticals Business Overview
11.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Introduction
11.8.4 Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.8.5 Salix Pharmaceuticals Recent Development
11.9 Perrigo
11.9.1 Perrigo Company Details
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Pediatric Gastrointestinal Drugs Introduction
11.9.4 Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.9.5 Perrigo Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Pediatric Gastrointestinal Drugs Introduction
11.10.4 Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.10.5 Abbott Recent Development
11.11 Honz Pharmaceutical
11.11.1 Honz Pharmaceutical Company Details
11.11.2 Honz Pharmaceutical Business Overview
11.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.11.4 Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.11.5 Honz Pharmaceutical Recent Development
11.12 Shandong DYNE Marine Biopharmaceutical
11.12.1 Shandong DYNE Marine Biopharmaceutical Company Details
11.12.2 Shandong DYNE Marine Biopharmaceutical Business Overview
11.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.12.4 Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.12.5 Shandong DYNE Marine Biopharmaceutical Recent Development
11.13 Sunflower Pharmaceutical
11.13.1 Sunflower Pharmaceutical Company Details
11.13.2 Sunflower Pharmaceutical Business Overview
11.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.13.4 Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.13.5 Sunflower Pharmaceutical Recent Development
11.14 Jiangzhong Pharmaceutical
11.14.1 Jiangzhong Pharmaceutical Company Details
11.14.2 Jiangzhong Pharmaceutical Business Overview
11.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.14.4 Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.14.5 Jiangzhong Pharmaceutical Recent Development
11.15 Yabao Pharmaceutical
11.15.1 Yabao Pharmaceutical Company Details
11.15.2 Yabao Pharmaceutical Business Overview
11.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.15.4 Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.15.5 Yabao Pharmaceutical Recent Development
11.16 Jumpcan Pharmaceutical
11.16.1 Jumpcan Pharmaceutical Company Details
11.16.2 Jumpcan Pharmaceutical Business Overview
11.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.16.4 Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.16.5 Jumpcan Pharmaceutical Recent Development
11.17 Hansen Pharmaceutical
11.17.1 Hansen Pharmaceutical Company Details
11.17.2 Hansen Pharmaceutical Business Overview
11.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.17.4 Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025)
11.17.5 Hansen Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Sanofi
Aptalis
Eisai Co Ltd
Pfizer Inc
Zeria（Tillotts）
GlaxoSmithKline PLC
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Hansen Pharmaceutical
List of Tables
 Table 1. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablets
 Table 3. Key Players of Pills
 Table 4. Key Players of Oral Liquid
 Table 5. Global Pediatric Gastrointestinal Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pediatric Gastrointestinal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pediatric Gastrointestinal Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Pediatric Gastrointestinal Drugs Market Share by Region (2020-2025)
 Table 9. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Pediatric Gastrointestinal Drugs Market Share by Region (2026-2031)
 Table 11. Pediatric Gastrointestinal Drugs Market Trends
 Table 12. Pediatric Gastrointestinal Drugs Market Drivers
 Table 13. Pediatric Gastrointestinal Drugs Market Challenges
 Table 14. Pediatric Gastrointestinal Drugs Market Restraints
 Table 15. Global Pediatric Gastrointestinal Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Pediatric Gastrointestinal Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Pediatric Gastrointestinal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2024)
 Table 18. Ranking of Global Top Pediatric Gastrointestinal Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Pediatric Gastrointestinal Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Pediatric Gastrointestinal Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Pediatric Gastrointestinal Drugs, Product and Application
 Table 22. Global Key Players of Pediatric Gastrointestinal Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pediatric Gastrointestinal Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Pediatric Gastrointestinal Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. AstraZeneca Company Details
 Table 48. AstraZeneca Business Overview
 Table 49. AstraZeneca Pediatric Gastrointestinal Drugs Product
 Table 50. AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 51. AstraZeneca Recent Development
 Table 52. Sanofi Company Details
 Table 53. Sanofi Business Overview
 Table 54. Sanofi Pediatric Gastrointestinal Drugs Product
 Table 55. Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 56. Sanofi Recent Development
 Table 57. Aptalis Company Details
 Table 58. Aptalis Business Overview
 Table 59. Aptalis Pediatric Gastrointestinal Drugs Product
 Table 60. Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 61. Aptalis Recent Development
 Table 62. Eisai Company Details
 Table 63. Eisai Business Overview
 Table 64. Eisai Pediatric Gastrointestinal Drugs Product
 Table 65. Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 66. Eisai Recent Development
 Table 67. Pfizer Company Details
 Table 68. Pfizer Business Overview
 Table 69. Pfizer Pediatric Gastrointestinal Drugs Product
 Table 70. Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 71. Pfizer Recent Development
 Table 72. Zeria (Tillotts) Company Details
 Table 73. Zeria (Tillotts) Business Overview
 Table 74. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product
 Table 75. Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 76. Zeria (Tillotts) Recent Development
 Table 77. GlaxoSmithKline Company Details
 Table 78. GlaxoSmithKline Business Overview
 Table 79. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product
 Table 80. GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 81. GlaxoSmithKline Recent Development
 Table 82. Salix Pharmaceuticals Company Details
 Table 83. Salix Pharmaceuticals Business Overview
 Table 84. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product
 Table 85. Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 86. Salix Pharmaceuticals Recent Development
 Table 87. Perrigo Company Details
 Table 88. Perrigo Business Overview
 Table 89. Perrigo Pediatric Gastrointestinal Drugs Product
 Table 90. Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 91. Perrigo Recent Development
 Table 92. Abbott Company Details
 Table 93. Abbott Business Overview
 Table 94. Abbott Pediatric Gastrointestinal Drugs Product
 Table 95. Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 96. Abbott Recent Development
 Table 97. Honz Pharmaceutical Company Details
 Table 98. Honz Pharmaceutical Business Overview
 Table 99. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product
 Table 100. Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 101. Honz Pharmaceutical Recent Development
 Table 102. Shandong DYNE Marine Biopharmaceutical Company Details
 Table 103. Shandong DYNE Marine Biopharmaceutical Business Overview
 Table 104. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product
 Table 105. Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 106. Shandong DYNE Marine Biopharmaceutical Recent Development
 Table 107. Sunflower Pharmaceutical Company Details
 Table 108. Sunflower Pharmaceutical Business Overview
 Table 109. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product
 Table 110. Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 111. Sunflower Pharmaceutical Recent Development
 Table 112. Jiangzhong Pharmaceutical Company Details
 Table 113. Jiangzhong Pharmaceutical Business Overview
 Table 114. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product
 Table 115. Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 116. Jiangzhong Pharmaceutical Recent Development
 Table 117. Yabao Pharmaceutical Company Details
 Table 118. Yabao Pharmaceutical Business Overview
 Table 119. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product
 Table 120. Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 121. Yabao Pharmaceutical Recent Development
 Table 122. Jumpcan Pharmaceutical Company Details
 Table 123. Jumpcan Pharmaceutical Business Overview
 Table 124. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product
 Table 125. Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 126. Jumpcan Pharmaceutical Recent Development
 Table 127. Hansen Pharmaceutical Company Details
 Table 128. Hansen Pharmaceutical Business Overview
 Table 129. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product
 Table 130. Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2020-2025) & (US$ Million)
 Table 131. Hansen Pharmaceutical Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Pediatric Gastrointestinal Drugs Picture
 Figure 2. Global Pediatric Gastrointestinal Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pediatric Gastrointestinal Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Tablets Features
 Figure 5. Pills Features
 Figure 6. Oral Liquid Features
 Figure 7. Global Pediatric Gastrointestinal Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pediatric Gastrointestinal Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Pharmacies Case Studies
 Figure 10. Online Pharmacies Case Studies
 Figure 11. Retail Pharmacies Case Studies
 Figure 12. Pediatric Gastrointestinal Drugs Report Years Considered
 Figure 13. Global Pediatric Gastrointestinal Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pediatric Gastrointestinal Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pediatric Gastrointestinal Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Pediatric Gastrointestinal Drugs Market Share by Players in 2024
 Figure 17. Global Top Pediatric Gastrointestinal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pediatric Gastrointestinal Drugs Revenue in 2024
 Figure 19. North America Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pediatric Gastrointestinal Drugs Market Share by Country (2020-2031)
 Figure 21. United States Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pediatric Gastrointestinal Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pediatric Gastrointestinal Drugs Market Share by Region (2020-2031)
 Figure 33. China Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pediatric Gastrointestinal Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pediatric Gastrointestinal Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pediatric Gastrointestinal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. AstraZeneca Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 49. Sanofi Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 50. Aptalis Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 51. Eisai Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 52. Pfizer Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 53. Zeria (Tillotts) Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 54. GlaxoSmithKline Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 55. Salix Pharmaceuticals Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 56. Perrigo Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 57. Abbott Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 58. Honz Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 59. Shandong DYNE Marine Biopharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 60. Sunflower Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 61. Jiangzhong Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 62. Yabao Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 63. Jumpcan Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 64. Hansen Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Pediatric Digestive Drugs Market Research Report 2025
Global Gastrointestinal Device Market Research Report 2025
Global Gastrointestinal GI Devices Market Research Report 2025
Global Gastrointestinal Motility Drugs Market Research Report 2024
Global Medication For Gastrointestinal Bleeding Market Research Report 2024
Global Gastrointestinal Rare Diseases Treatment Market Research Report 2025
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Clinical Trials Market Research Report 2024
Global Digestive System Drugs Market Research Report 2024
Global Pediatric ADHD Drugs Market Research Report 2025
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Medicines Market Research Report 2024
Global Children s Health Product Market Research Report 2024
Children Stomach Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intestinal Anti infective Drugs Market Research Report 2024
Pediatric Endoscopy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Forcep Market Research Report 2024
Digestive Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Stromal Tumors Therapeutics Market Research Report 2025
Global Gastro Enterology Disposable Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions